INS316
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for INS316, covering 2013-06-26 to 2015-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701) [Phase 2]